Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Drop in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIXGet Free Report) saw a large decline in short interest in November. As of November 30th, there was short interest totalling 36,600 shares, a decline of 21.8% from the November 15th total of 46,800 shares. Based on an average trading volume of 518,100 shares, the days-to-cover ratio is presently 0.1 days. Approximately 5.8% of the company’s shares are sold short.

Autonomix Medical Price Performance

Autonomix Medical stock opened at $3.19 on Friday. The company has a quick ratio of 4.26, a current ratio of 4.26 and a debt-to-equity ratio of 0.36. Autonomix Medical has a 52-week low of $3.01 and a 52-week high of $152.00. The firm has a market cap of $3.67 million and a PE ratio of -0.20. The company’s 50 day moving average is $9.37 and its two-hundred day moving average is $15.98.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH started coverage on shares of Autonomix Medical in a research report on Tuesday, September 3rd. They set a “buy” rating and a $28.00 price target on the stock.

View Our Latest Stock Analysis on Autonomix Medical

Autonomix Medical Company Profile

(Get Free Report)

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.

Featured Stories

Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.